USPTO trademark

MIGRAINE ON THE MIND

RegisteredUSPTOWord markClass 35Class 41Class 44

"MIGRAINE ON THE MIND" is a word mark owned by Allergan Pharmaceuticals International Limited, filed at the USPTO on April 3, 2025. It is registered and covers classes 35, 41 and 44.

View Allergan Pharmaceuticals International Limited portfolioGet this data via the API
Official USPTO record
MIGRAINE ON THE MIND trademark as filed
As filed with the USPTO
Status
Registered
Since February 3, 2026
Filed
April 3, 2025
Registered
February 3, 2026
Expires
Not recorded
Application no.
99119927
Registration no.
8124088
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns MIGRAINE ON THE MIND

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Allergan Pharmaceuticals International Limited

Dublin, Ireland

321 trademarks in the portfolioView company

Representative

Sonali S. Srivastava

AbbVie Inc.

Goods and services

What the mark covers

The products and services MIGRAINE ON THE MIND is filed for, grouped by Nice class.

  • Promoting public awareness of migraine disease

  • Providing a website featuring resources, namely, non-downloadable publications in the nature of articles, books, magazines and brochures in the field of migraine disease; educational services, namely, providing and conducting courses of instruction, seminars, conferences, workshops, training, symposiums and lectures in the field of migraine disease and distribution of educational materials in connection therewith; educational services, namely, organizing events in the field of migraine disease for educational purposes; educational services, namely, providing podcasts in the field of migraine disease; educational services, namely, providing on-line non-downloadable articles in the field migraine disease; entertainment services, namely, arranging special events for social entertainment purposes and arranging educational lectures and presentations in the nature of disease awareness campaigns, conferences, seminars and symposiums for the public, all in the field of migraine disease; providing on-line videos featuring information in the field of migraine disease, not downloadable; on-line journals, namely, blogs featuring information in the field of migraine disease.

  • Providing a website featuring health and medical information about migraine disease; providing health and medical information about migraine disease though social media platforms.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Teas/email correspondence entered
  8. Correspondence received in law office
  9. Teas response to office action received
  10. Application extension granted/receipt provided

8 earlier steps on the official record.

FAQ

About MIGRAINE ON THE MIND

Who owns the trademark "MIGRAINE ON THE MIND"?

The USPTO trademark "MIGRAINE ON THE MIND" (application 99119927) is owned by Allergan Pharmaceuticals International Limited.

What is the status of "MIGRAINE ON THE MIND"?

Its status at the USPTO is: registered.

When was "MIGRAINE ON THE MIND" registered?

It was registered on February 3, 2026.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull MIGRAINE ON THE MIND and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2aa3-4a72-72dc-bdfa-4c1288c3d173
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2aa3-4a72-72dc-bdfa-4c1288c3d173",
  "object": "trademark",
  "mark_text": "MIGRAINE ON THE MIND",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "99119927",
  "filing_date": "2025-04-03",
  "nice_classes": [
    35,
    41,
    44
  ],
  "owners": [
    {
      "name": "Allergan Pharmaceuticals International Limited",
      "entity_id": "ent_019eb6f6-367b-76c9-bac1-b8a3940da1c9"
    }
  ]
}